--2024/Q3-- / 12.869M--
--2024/Q2-- / 12.414M--
--2024/Q17.410M / 14.664M--
--2023/Q4316.192M / 33.673M--
--2023/Q317.193M / 23.893M--
US Stock MarketDetailed Quotes
BEAM Beam Therapeutics
- 25.460
- -1.470-5.46%
Close Jul 18 16:00 ET
- 25.460
- 0.0000.00%
Post 17:02 ET
2.10BMarket Cap-15912P/E (TTM)
27.470High25.410Low1.76MVolume26.840Open26.930Pre Close45.72MTurnover2.30%Turnover RatioLossP/E (Static)82.31MShares49.50052wk High2.29P/B1.95BFloat Cap16.95052wk Low--Dividend TTM76.56MShs Float138.522Historical High--Div YieldTTM7.65%Amplitude13.000Historical Low25.976Avg Price1Lot Size
Beam Therapeutics Key Stats
Beam Therapeutics Earnings Date
Currency: USD
Period
Q1 FY2024 Earnings
--
Revenue(YoY)
7.41M
-69.39%EPS(YoY)
-1.21
+9.02%Analyst Rating
Jul 18, 2024
Beam Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Beam Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
